FindTrial
Sign In

EFFICACY OF BRAHMI VATI AND ASHWAGANDHARISHTA IN Generalized anxiety disorder

Efficacy of brahmi vati and ashwagandharishta in (chittodwega) generalized anxiety disorder- Randomized controlled clinical trail - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085692
Enrollment
68
Registered
2025-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Dr anjali punia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the HAM-A Scale and QOL (Quality of Life) Assessment Criteria for Generalized Anxiety Disorder. 2. Age group between 16-60 years

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA [19] 1. Patients presenting with Major Organic Disorders and Psychotic Disorders 2. Patients below 16 years of age and above 60 years 3. Patients suffering from any other serious illness 4. Alcoholic, and self-harm or suicide risk. 5. Diagnosed with psychosis, schizophrenia, or bipolar illness currently or in the past. 6. Treatment with sertraline for two or more weeks within the previous three months. 7. Pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Improvement in the Hamilton Anxiety Scale score, WHO- Quality of Life,Timepoint: 0, 30, 60—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDr RAKESH PAWAR
anjali.punia1991@gmail.com7505039976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026